164 related articles for article (PubMed ID: 2892256)
1. The 24-hour acid suppression profile of nizatidine.
Dammann HG; Gottlieb WR; Walter TA; Müller P; Simon B; Keohane P
Scand J Gastroenterol Suppl; 1987; 136():56-60. PubMed ID: 2892256
[TBL] [Abstract][Full Text] [Related]
2. Nocturnal acid suppression with a new H2 receptor antagonist--nizatidine.
Dammann HG; Gottlieb WR; Walter TA; Dreyer M; Müller P; Simon B; Keohane P
Hepatogastroenterology; 1986 Oct; 33(5):217-20. PubMed ID: 2879782
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition of 24-hour acidity by nizatidine].
Dammann HG; Dreyer M; Gottlieb WR; Wolf N; Müller P; Simon B
Fortschr Med; 1989 May; 107(14):321-4. PubMed ID: 2568971
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.
Savarino V; Mela GS; Zentilin P; Scalabrini P; Bonifacino G; Gambaro P; Celle G
Digestion; 1989; 42(1):1-6. PubMed ID: 2568299
[TBL] [Abstract][Full Text] [Related]
5. Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine.
Nwokolo CU; Smith JT; Gavey C; Sawyerr A; Pounder RE
Aliment Pharmacol Ther; 1990; 4 Suppl 1():29-45. PubMed ID: 1983345
[TBL] [Abstract][Full Text] [Related]
6. Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h.
Lanzon-Miller S; Pounder RE; Chronos NA; Raymond F; Hamilton MR; Dalgleish D
Gut; 1988 Oct; 29(10):1364-9. PubMed ID: 2904394
[TBL] [Abstract][Full Text] [Related]
7. Double blind comparison of the effects of cimetidine, ranitidine, famotidine, and placebo on intragastric acidity in 30 normal volunteers.
Merki HS; Witzel L; Walt RP; Neumann J; Scheurle E; Mappes A; Krammisch H; Heim J; Kaufmann D; Roehmel J
Gut; 1988 Jan; 29(1):81-4. PubMed ID: 2893761
[TBL] [Abstract][Full Text] [Related]
8. Rebound hypersecretion after H2-antagonist withdrawal--a comparative study with nizatidine, ranitidine and famotidine.
Fullarton GM; Macdonald AM; McColl KE
Aliment Pharmacol Ther; 1991 Aug; 5(4):391-8. PubMed ID: 1685675
[TBL] [Abstract][Full Text] [Related]
9. Continuous intragastric pH monitoring: a real progress in the assessment of antisecretory drugs.
Savarino V
Ital J Gastroenterol; 1990; 22 Suppl 2():20-3. PubMed ID: 1983412
[TBL] [Abstract][Full Text] [Related]
10. Effect of nizatidine and cimetidine on betazole-stimulated gastric secretion of normal subjects: comparison of effects on acid, water, and pepsin.
Hammond JB; Offen WW
Am J Gastroenterol; 1988 Jan; 83(1):32-6. PubMed ID: 2892392
[TBL] [Abstract][Full Text] [Related]
11. Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer.
Savarino V; Mela GS; Zentilin P; Bonifacino G; Moretti M; Valle F; Celle G
Dig Dis Sci; 1989 Jul; 34(7):1043-6. PubMed ID: 2568246
[TBL] [Abstract][Full Text] [Related]
12. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade.
Nwokolo CU; Smith JT; Sawyerr AM; Pounder RE
Gut; 1991 Dec; 32(12):1455-60. PubMed ID: 1685465
[TBL] [Abstract][Full Text] [Related]
13. [Nizatidine versus ranitidine in the treatment of acute duodenal ulcer. Comparison of 300 mg nizatidine and 300 mg ranitidine in a single evening dose].
Arnold R; Beckenbach P; Bock H; Bormann R; Daake H; Dammann HG; Du Bosque G; Fürer M; Geiter B; Hebbeln H
Fortschr Med; 1989 Jul; 107(21):467-70. PubMed ID: 2570012
[TBL] [Abstract][Full Text] [Related]
14. Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist.
Fullarton GM; McLauchlan G; Macdonald A; Crean GP; McColl KE
Gut; 1989 Apr; 30(4):449-54. PubMed ID: 2565860
[TBL] [Abstract][Full Text] [Related]
15. Effect of oral famotidine on 24-hour intragastric acidity.
Santana IA; Lanzon-Miller S; Pounder RE
Postgrad Med J; 1986; 62 Suppl 2():39-42. PubMed ID: 2890150
[TBL] [Abstract][Full Text] [Related]
16. 300 mg nizatidine at night versus 300 mg ranitidine at night in patients with duodenal ulcer. A multicentre trial in Europe.
Simon B; Cremer M; Dammann HG; Hentschel E; Keohane PP; Mulder H; Müller P; Sarles H
Scand J Gastroenterol Suppl; 1987; 136():61-70. PubMed ID: 2892257
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and pharmacodynamics of oral nizatidine.
Vargas R; Ryan J; McMahon FG; Regel G; Offen WW; Matsumoto C
J Clin Pharmacol; 1988 Jan; 28(1):71-5. PubMed ID: 2895125
[TBL] [Abstract][Full Text] [Related]
18. Comparison of famotidine with cimetidine and ranitidine.
Berardi RR; Tankanow RM; Nostrant TT
Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
[TBL] [Abstract][Full Text] [Related]
19. Twenty-four-hour control of gastric acidity by twice-daily doses of placebo, nizatidine 150 mg, nizatidine 300 mg, and ranitidine 300 mg.
Savarino V; Mela GS; Zentilin P; Cutela P; Mele R; Celle G
J Clin Pharmacol; 1993 Jan; 33(1):70-4. PubMed ID: 8429117
[TBL] [Abstract][Full Text] [Related]
20. Nizatidine versus ranitidine in gastric ulcer disease. A European multicentre trial.
Naccaratto R; Cremer M; Dammann HG; Keohane PP; Mulder H; Sarles H; Simon B
Scand J Gastroenterol Suppl; 1987; 136():71-8. PubMed ID: 2892258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]